Results of surgery for primary lung cancer based on the new international staging system
This study clarified the results of surgery for primary lung cancer based on the new international staging system. On December 1997, the Japan Lung Cancer Society adopted a new TNM staging system which had already received international recognition. The subjects of this study were 1062 consecutive p...
Gespeichert in:
| Veröffentlicht in: | General thoracic and cardiovascular surgery 1999-07, Vol.47 (7), p.313-317 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 317 |
|---|---|
| container_issue | 7 |
| container_start_page | 313 |
| container_title | General thoracic and cardiovascular surgery |
| container_volume | 47 |
| creator | Koike, T Terashima, M Takizawa, T Aoki, T Watanabe, T Akamatsu, H |
| description | This study clarified the results of surgery for primary lung cancer based on the new international staging system.
On December 1997, the Japan Lung Cancer Society adopted a new TNM staging system which had already received international recognition.
The subjects of this study were 1062 consecutive previously untreated patients who underwent pulmonary resection for primary non-small cell lung cancer between January 1975 and December 1992.
The postoperative 5-year survival rate for all patients was 58.5%. Pathological staging demonstrated a survival rate which was 73.2% in stage I, 46.8% in stage II, 26.7% in stage III, and 20.0% in stage IV. In the staging subgroups, the survival rate was 79.6% in stage IA, 62.4% in stage IB, 62.2% in stage IIA, 42.0% in stage IIB, 26.9% in stage IIIA, and 26.3% in stage IIIB. Concerning the pm patients, the survival rate was 20.2% in pm1 and 20.0% in pm2, while the survival rate of the patients with N0 was 45.7% in pm1 and 40.0% in pm2.
A significant difference in the 5-year survival rate was recognized between the new stages IA and IB, and between the new stages IIA and IIB. When pm patients are diagnosed without lymph node metastasis, the opportunity for resection should not be lost. |
| doi_str_mv | 10.1007/bf03218017 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2918734434</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2918734434</sourcerecordid><originalsourceid>FETCH-LOGICAL-c290t-f2c7a1de6033ca2457320bc9a12d5d9fbffa8afd408a3682fe95c9a5e92bf5093</originalsourceid><addsrcrecordid>eNpNkF1LwzAUhoMobk5v_AES8E6onny0SS51-AUDQRS8K2l7Mju6diYpsn9vZBO8Oi-ch5dzHkLOGVwzAHVTORCcaWDqgEyZLkTGwfDDlIWUmTSFnJCTEFYAUuXKHJMJA6mZ0HpKPl4xjF0MdHA0jH6Jfkvd4OnGt2ubcjf2S1rbvkZPKxuwoUNP4yfSHr9p20f0vY3t0NuOhmiXbaLDNkRcn5IjZ7uAZ_s5I-8P92_zp2zx8vg8v11kNTcQM8drZVmDBQhRWy5zJThUtbGMN3ljXOWc1dY1ErQVheYOTZ62ORpeuRyMmJHLXe_GD18jhliuhjEd1YWSG6ZVUiBkoq52VO2HEDy6cv9gyaD8lVjePfxJTPDFvnKs1tj8Q3fWxA_jr20H</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2918734434</pqid></control><display><type>article</type><title>Results of surgery for primary lung cancer based on the new international staging system</title><source>MEDLINE</source><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central UK/Ireland</source><source>SpringerLink Journals - AutoHoldings</source><source>ProQuest Central</source><creator>Koike, T ; Terashima, M ; Takizawa, T ; Aoki, T ; Watanabe, T ; Akamatsu, H</creator><creatorcontrib>Koike, T ; Terashima, M ; Takizawa, T ; Aoki, T ; Watanabe, T ; Akamatsu, H</creatorcontrib><description>This study clarified the results of surgery for primary lung cancer based on the new international staging system.
On December 1997, the Japan Lung Cancer Society adopted a new TNM staging system which had already received international recognition.
The subjects of this study were 1062 consecutive previously untreated patients who underwent pulmonary resection for primary non-small cell lung cancer between January 1975 and December 1992.
The postoperative 5-year survival rate for all patients was 58.5%. Pathological staging demonstrated a survival rate which was 73.2% in stage I, 46.8% in stage II, 26.7% in stage III, and 20.0% in stage IV. In the staging subgroups, the survival rate was 79.6% in stage IA, 62.4% in stage IB, 62.2% in stage IIA, 42.0% in stage IIB, 26.9% in stage IIIA, and 26.3% in stage IIIB. Concerning the pm patients, the survival rate was 20.2% in pm1 and 20.0% in pm2, while the survival rate of the patients with N0 was 45.7% in pm1 and 40.0% in pm2.
A significant difference in the 5-year survival rate was recognized between the new stages IA and IB, and between the new stages IIA and IIB. When pm patients are diagnosed without lymph node metastasis, the opportunity for resection should not be lost.</description><identifier>ISSN: 1344-4964</identifier><identifier>ISSN: 1863-6705</identifier><identifier>EISSN: 1863-2092</identifier><identifier>EISSN: 1863-6713</identifier><identifier>DOI: 10.1007/bf03218017</identifier><identifier>PMID: 10481388</identifier><language>eng</language><publisher>Japan: Springer Nature B.V</publisher><subject>Carcinoma, Non-Small-Cell Lung - mortality ; Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - surgery ; Humans ; Lung cancer ; Lung Neoplasms - mortality ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Neoplasm Staging - standards ; Pneumonectomy ; Survival Rate</subject><ispartof>General thoracic and cardiovascular surgery, 1999-07, Vol.47 (7), p.313-317</ispartof><rights>The Japanese Society of Thoracic and Cadiovascular Surgery 1999.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c290t-f2c7a1de6033ca2457320bc9a12d5d9fbffa8afd408a3682fe95c9a5e92bf5093</citedby><cites>FETCH-LOGICAL-c290t-f2c7a1de6033ca2457320bc9a12d5d9fbffa8afd408a3682fe95c9a5e92bf5093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2918734434?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,21388,21389,27924,27925,33530,33744,43659,43805,64385,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10481388$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koike, T</creatorcontrib><creatorcontrib>Terashima, M</creatorcontrib><creatorcontrib>Takizawa, T</creatorcontrib><creatorcontrib>Aoki, T</creatorcontrib><creatorcontrib>Watanabe, T</creatorcontrib><creatorcontrib>Akamatsu, H</creatorcontrib><title>Results of surgery for primary lung cancer based on the new international staging system</title><title>General thoracic and cardiovascular surgery</title><addtitle>Jpn J Thorac Cardiovasc Surg</addtitle><description>This study clarified the results of surgery for primary lung cancer based on the new international staging system.
On December 1997, the Japan Lung Cancer Society adopted a new TNM staging system which had already received international recognition.
The subjects of this study were 1062 consecutive previously untreated patients who underwent pulmonary resection for primary non-small cell lung cancer between January 1975 and December 1992.
The postoperative 5-year survival rate for all patients was 58.5%. Pathological staging demonstrated a survival rate which was 73.2% in stage I, 46.8% in stage II, 26.7% in stage III, and 20.0% in stage IV. In the staging subgroups, the survival rate was 79.6% in stage IA, 62.4% in stage IB, 62.2% in stage IIA, 42.0% in stage IIB, 26.9% in stage IIIA, and 26.3% in stage IIIB. Concerning the pm patients, the survival rate was 20.2% in pm1 and 20.0% in pm2, while the survival rate of the patients with N0 was 45.7% in pm1 and 40.0% in pm2.
A significant difference in the 5-year survival rate was recognized between the new stages IA and IB, and between the new stages IIA and IIB. When pm patients are diagnosed without lymph node metastasis, the opportunity for resection should not be lost.</description><subject>Carcinoma, Non-Small-Cell Lung - mortality</subject><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Humans</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - mortality</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Neoplasm Staging - standards</subject><subject>Pneumonectomy</subject><subject>Survival Rate</subject><issn>1344-4964</issn><issn>1863-6705</issn><issn>1863-2092</issn><issn>1863-6713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpNkF1LwzAUhoMobk5v_AES8E6onny0SS51-AUDQRS8K2l7Mju6diYpsn9vZBO8Oi-ch5dzHkLOGVwzAHVTORCcaWDqgEyZLkTGwfDDlIWUmTSFnJCTEFYAUuXKHJMJA6mZ0HpKPl4xjF0MdHA0jH6Jfkvd4OnGt2ubcjf2S1rbvkZPKxuwoUNP4yfSHr9p20f0vY3t0NuOhmiXbaLDNkRcn5IjZ7uAZ_s5I-8P92_zp2zx8vg8v11kNTcQM8drZVmDBQhRWy5zJThUtbGMN3ljXOWc1dY1ErQVheYOTZ62ORpeuRyMmJHLXe_GD18jhliuhjEd1YWSG6ZVUiBkoq52VO2HEDy6cv9gyaD8lVjePfxJTPDFvnKs1tj8Q3fWxA_jr20H</recordid><startdate>199907</startdate><enddate>199907</enddate><creator>Koike, T</creator><creator>Terashima, M</creator><creator>Takizawa, T</creator><creator>Aoki, T</creator><creator>Watanabe, T</creator><creator>Akamatsu, H</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope></search><sort><creationdate>199907</creationdate><title>Results of surgery for primary lung cancer based on the new international staging system</title><author>Koike, T ; Terashima, M ; Takizawa, T ; Aoki, T ; Watanabe, T ; Akamatsu, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c290t-f2c7a1de6033ca2457320bc9a12d5d9fbffa8afd408a3682fe95c9a5e92bf5093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Carcinoma, Non-Small-Cell Lung - mortality</topic><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Humans</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - mortality</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Neoplasm Staging - standards</topic><topic>Pneumonectomy</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koike, T</creatorcontrib><creatorcontrib>Terashima, M</creatorcontrib><creatorcontrib>Takizawa, T</creatorcontrib><creatorcontrib>Aoki, T</creatorcontrib><creatorcontrib>Watanabe, T</creatorcontrib><creatorcontrib>Akamatsu, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>General thoracic and cardiovascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koike, T</au><au>Terashima, M</au><au>Takizawa, T</au><au>Aoki, T</au><au>Watanabe, T</au><au>Akamatsu, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Results of surgery for primary lung cancer based on the new international staging system</atitle><jtitle>General thoracic and cardiovascular surgery</jtitle><addtitle>Jpn J Thorac Cardiovasc Surg</addtitle><date>1999-07</date><risdate>1999</risdate><volume>47</volume><issue>7</issue><spage>313</spage><epage>317</epage><pages>313-317</pages><issn>1344-4964</issn><issn>1863-6705</issn><eissn>1863-2092</eissn><eissn>1863-6713</eissn><abstract>This study clarified the results of surgery for primary lung cancer based on the new international staging system.
On December 1997, the Japan Lung Cancer Society adopted a new TNM staging system which had already received international recognition.
The subjects of this study were 1062 consecutive previously untreated patients who underwent pulmonary resection for primary non-small cell lung cancer between January 1975 and December 1992.
The postoperative 5-year survival rate for all patients was 58.5%. Pathological staging demonstrated a survival rate which was 73.2% in stage I, 46.8% in stage II, 26.7% in stage III, and 20.0% in stage IV. In the staging subgroups, the survival rate was 79.6% in stage IA, 62.4% in stage IB, 62.2% in stage IIA, 42.0% in stage IIB, 26.9% in stage IIIA, and 26.3% in stage IIIB. Concerning the pm patients, the survival rate was 20.2% in pm1 and 20.0% in pm2, while the survival rate of the patients with N0 was 45.7% in pm1 and 40.0% in pm2.
A significant difference in the 5-year survival rate was recognized between the new stages IA and IB, and between the new stages IIA and IIB. When pm patients are diagnosed without lymph node metastasis, the opportunity for resection should not be lost.</abstract><cop>Japan</cop><pub>Springer Nature B.V</pub><pmid>10481388</pmid><doi>10.1007/bf03218017</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1344-4964 |
| ispartof | General thoracic and cardiovascular surgery, 1999-07, Vol.47 (7), p.313-317 |
| issn | 1344-4964 1863-6705 1863-2092 1863-6713 |
| language | eng |
| recordid | cdi_proquest_journals_2918734434 |
| source | MEDLINE; ProQuest Central (Alumni Edition); ProQuest Central UK/Ireland; SpringerLink Journals - AutoHoldings; ProQuest Central |
| subjects | Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - surgery Humans Lung cancer Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - surgery Neoplasm Staging - standards Pneumonectomy Survival Rate |
| title | Results of surgery for primary lung cancer based on the new international staging system |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T21%3A04%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Results%20of%20surgery%20for%20primary%20lung%20cancer%20based%20on%20the%20new%20international%20staging%20system&rft.jtitle=General%20thoracic%20and%20cardiovascular%20surgery&rft.au=Koike,%20T&rft.date=1999-07&rft.volume=47&rft.issue=7&rft.spage=313&rft.epage=317&rft.pages=313-317&rft.issn=1344-4964&rft.eissn=1863-2092&rft_id=info:doi/10.1007/bf03218017&rft_dat=%3Cproquest_cross%3E2918734434%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2918734434&rft_id=info:pmid/10481388&rfr_iscdi=true |